Total Payments
$7,558
2023 Payments
$17.81
Companies
59
Transactions
539
Medicare Patients
1,763
Medicare Billing
$184,404
Payment Breakdown by Category
Food & Beverage$7,405 (98.0%)
Education$137.07 (1.8%)
Other$15.86 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,405 | 535 | 98.0% |
| Education | $137.07 | 3 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.86 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $553.09 | 30 | $0 (2022) |
| ABBVIE INC. | $514.39 | 49 | $0 (2022) |
| Harmony Biosciences LLC | $506.07 | 31 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $495.71 | 59 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $453.14 | 31 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $435.19 | 29 | $0 (2022) |
| EISAI INC. | $381.19 | 25 | $0 (2022) |
| UCB, Inc. | $325.03 | 28 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $291.23 | 24 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $267.76 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.81 | 1 | PFIZER INC. ($17.81) |
| 2022 | $2,136 | 143 | Harmony Biosciences LLC ($279.63) |
| 2021 | $1,430 | 114 | AbbVie Inc. ($234.95) |
| 2020 | $358.41 | 26 | Supernus Pharmaceuticals, Inc. ($128.74) |
| 2019 | $1,026 | 66 | Supernus Pharmaceuticals, Inc. ($196.25) |
| 2018 | $1,758 | 135 | Teva Pharmaceuticals USA, Inc. ($187.82) |
| 2017 | $831.80 | 54 | Sunovion Pharmaceuticals Inc. ($149.01) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/03/2023 | PFIZER INC. | PANZYGA (Biological), PAXLOVID | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/12/2022 | PFIZER INC. | PANZYGA (Biological), PAXLOVID | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/26/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neuroscience | ||||||
| 10/26/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Neurology | ||||||
| 10/19/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.29 | General |
| Category: Neurology | ||||||
| 10/17/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: NEUROLOGY | ||||||
| 10/12/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Neuroscience | ||||||
| 10/11/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: PRIMARY CARE | ||||||
| 10/11/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: PRIMARY CARE | ||||||
| 09/21/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Central Nervous System | ||||||
| 09/19/2022 | Collegium Pharmaceutical, Inc. | ELYXYB - celecoxib (Drug) | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| Category: Migraine | ||||||
| 09/12/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Neurology | ||||||
| 09/11/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: NEUROLOGY | ||||||
| 09/02/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $10.33 | General |
| Category: Neurological Disorders | ||||||
| 08/30/2022 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Neurology | ||||||
| 08/29/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Neuroscience | ||||||
| 08/24/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: CNS | ||||||
| 08/23/2022 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Neurology | ||||||
| 08/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PRIMARY CARE | ||||||
| 08/09/2022 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: UPLIZNA | ||||||
| 08/07/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.19 | General |
| Category: NEUROLOGY | ||||||
| 08/04/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $30.99 | General |
| Category: Neurological Disorders | ||||||
| 08/04/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $3.33 | General |
| Category: Neurological Disorders | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 375 | 457 | $170,789 | $37,639 |
| 2021 | 8 | 592 | 721 | $275,333 | $62,213 |
| 2020 | 14 | 796 | 973 | $352,307 | $84,551 |
Total Patients
1,763
Total Services
2,151
Medicare Billing
$184,404
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 286 | 367 | $133,915 | $28,289 | 21.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 48 | 49 | $20,063 | $5,506 | 27.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 26 | 26 | $10,199 | $2,467 | 24.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 15 | 15 | $6,613 | $1,378 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 377 | 503 | $184,456 | $40,325 | 21.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $25,205 | $5,803 | 23.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 50 | 52 | $21,325 | $5,737 | 26.9% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 27 | 27 | $10,983 | $2,860 | 26.0% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 26 | 27 | $11,233 | $2,615 | 23.3% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 26 | 26 | $10,462 | $2,275 | 21.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 11 | 11 | $5,891 | $1,571 | 26.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 22 | 22 | $5,780 | $1,026 | 17.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 354 | 510 | $157,171 | $36,665 | 23.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 107 | 126 | $41,134 | $10,716 | 26.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 83 | 83 | $38,457 | $8,912 | 23.2% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Office | 2020 | 18 | 18 | $20,638 | $5,418 | 26.3% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 39 | 39 | $16,142 | $3,894 | 24.1% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 31 | 31 | $16,881 | $3,730 | 22.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2020 | 28 | 28 | $9,940 | $2,489 | 25.0% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2020 | 12 | 12 | $10,398 | $2,355 | 22.6% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 13 | 13 | $9,731 | $2,132 | 21.9% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2020 | 22 | 22 | $8,101 | $2,000 | 24.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 36 | $7,604 | $1,860 | 24.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $7,611 | $1,691 | 22.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 23 | $2,926 | $1,523 | 52.0% |
About Dr. Michael Levine, MD
Dr. Michael Levine, MD is a Neurology healthcare provider based in Noblesville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861490484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Levine, MD has received a total of $7,558 in payments from pharmaceutical and medical device companies, with $17.81 received in 2023. These payments were reported across 539 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($7,405).
As a Medicare-enrolled provider, Levine has provided services to 1,763 Medicare beneficiaries, totaling 2,151 services with total Medicare billing of $184,404. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Noblesville, IN
- Active Since 07/08/2005
- Last Updated 08/24/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861490484
Products in Payments
- Wakix (Drug) $506.07
- Fycompa (Drug) $381.19
- UBRELVY (Drug) $348.24
- APTIOM (Drug) $316.09
- Xyrem (Drug) $278.88
- NURTEC ODT (Drug) $278.61
- TROKENDI XR (Drug) $267.42
- OXTELLAR XR (Drug) $228.29
- Aimovig (Biological) $207.53
- AUBAGIO (Drug) $177.41
- Vimpat (Drug) $159.28
- Hizentra (Biological) $155.22
- SUNOSI (Drug) $151.50
- KESIMPTA (Drug) $151.19
- KYNMOBI (Drug) $137.05
- OCREVUS (Biological) $125.65
- NUEDEXTA (Drug) $120.50
- GILENYA (Drug) $119.48
- INGREZZA (Drug) $108.98
- Briviact (Drug) $108.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.